You just read:

MabVax Therapeutics HuMab-5B1 Based Diagnostic Imaging and Radioimmunotherapy Programs Featured at the 2016 World Molecular Imaging Congress

News provided by

MabVax Therapeutics Holdings, Inc.

Sep 26, 2016, 09:05 ET